BCLC GROUP
@BCLC_group
Followers
4K
Following
1K
Media
870
Statuses
2K
The BCLC group was created in 1986. We are a multidisciplinary group dedicated to the management and research in liver cancer.
Barcelona
Joined December 2015
This is what better exposes our task around diagnosis and treatment of liver cancer according to scientific evidence
journal-of-hepatology.eu
There have been major advances in the armamentarium for hepatocellular carcinoma (HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and treatment strategy published...
0
14
44
Our postdoc @martafortuny10 chairs the Symposium of Young Investigators in the 1st CIBERDEM-CIBEREHD Joint Conference. Step by step growth of a scientific career @SaludISCIII @idibaps
1
0
8
@hospitalclinic @ADC_CAT @ACCUCatalunya @SCDigestologia @AzucenaSalas17 Vols saber més sobre el càncer de fetge? 🗓️Apuntat a les visites guiades de dijous 20 de novembre a les 10:00 i a les 12.00 👉 https://t.co/R0XtBRBDTB
1
1
1
Aquesta setmana, a l'IDIBAPS... El grup de recerca d'Oncologia Hepàtica ha publicat la nova versió de les guies per al maneig del carcinoma hepatocel·lular Aquestes guies presenten un nou model per presonalitzar-ne el tractament 👉 https://t.co/rvMYKwft88
0
2
5
Hoy termina el mes de cáncer de Hígado, pero no el trabajo y compromiso conjunto para avanzar en concienciación #LiverCancerAwarenessMonth Una imagen más de mil palabras! @hospitalclinic @idibaps @ContraCancerEs @atuvibi
@ILCAnews @BCLC_group
0
8
28
#LiverCancerAwarenessMonth ends. In 2025 BCLC has contributed to HCC care. We highlight the updated BCLC model for treatment https://t.co/St4Rb8vWei, the HCC Lancet Commission https://t.co/sjnPXB7ZLu & the exposure of disparities in access to care https://t.co/4LqYaynDOU
0
5
22
@BCLC_group @idibaps @ma5RN @castells_toni @MeritxellMolla @bruixj @CIBER_ISCIII 📖 Las guías #BCLC2025, coordinadas por el @BCLC_group del #CLÍNIC-@idibaps, presentan el modelo CUSE para personalizar el tratamiento del cáncer de hígado. 🔬 Este nuevo enfoque contempla la complejidad, incertidumbre, subjetividad y emociones en la toma de decisiones clínicas.
0
4
8
📖 Les guies #BCLC2025, coordinades pel @BCLC_group del #CLÍNIC-@idibaps, presenten el model CUSE per personalitzar el tractament del càncer de fetge. 🔬 Aquest nou enfocament contempla la complexitat, incertesa, subjectivitat i emocions en la presa de decisions clíniques. 💡
1
12
22
🆕The Hepatic Oncology Research Group @BCLC_group has published the new version of the guidelines for the management of hepatocellular carcinoma, the most common primary liver cancer These guidelines present a new model for personalizing treatment 👉 https://t.co/AMNbBAzXUb
1
4
9
@BCLC_group BCLC 2025 update 🔝🔝 incorporates recent advances in the field of treatment recommendations for #HCC, such as #EBRT Amazing sessions and clinical scenarios discussion!!
0
4
10
The BCLC 2025 model for prognosis and treatment recommendation is available in press. https://t.co/xmSI9l6hoG In brief, it will be presented by @ma5RN with introduction of the CUSE concept https://t.co/eTbhfLufoL Major relevance for clinical decision making @hospitalclinic
journal-of-hepatology.eu
Lay Summary: The 2025 BCLC update maintains its clear, stage-based framework and ties each stage to the strongest evidence-based first treatment (see Figure 4). It also introduces the concept of...
0
16
30
Date for 2026 officially announced!! @hospitalclinic @ContraCancerEs @AEEHLiver @EASLnews @ILCAnews @AASLDtweets @myESMO
0
4
18
The BCLC 2025 update starts next Monday. We will have full room but virtual attendance is available. Worth to see the launch of the updated BCLC prognostic and treatment model for HCC @hospitalclinic @AEEHLiver @ILCAnews @EASLnews @AASLDtweets @ContraCancerEs @idibaps
0
12
36
Our very own @neusllarch exposes the value of Advanced Practice Nurse in teams devoted to liver cancer care. Nurses are key members of the BCLC and provide major insight in the weekly MDT @hospitalclinic @ContraCancerEs
📽️In this video, Neus Llarch, calls on liver cancer units and physicians to embrace #multidisciplinary collaboration. For this #LiverCancerAwarenessMonth, help us support inclusive, holistic approaches to liver cancer treatment to improve patient care.
0
3
10
🧬 ILCA Advocacy’s new paper in The Lancet Regional Health – Europe calls for global collaboration to ensure fair access to life-saving liver cancer treatments. 📕Read it now: https://t.co/D5ZGmLr1mX
#LiverCancerAwarenesMonth
thelancet.com
Hepatocellular carcinoma (HCC) is a major cause of cancer deaths worldwide. It is often diagnosed at advanced stages, requiring systemic therapies like sorafenib, lenvatinib, atezolizumab-bevacizum...
0
5
9
Nice involvement of @MarcoSanduzzi at the @aeeh translational meeting in Pamplona. Great recruit into the BCLC! @hospitalclinic @idibaps @ContraCancerEs
0
2
17
On October 9 our fellow @martafortuny10 received the @ContraCancerEs grant to further expand her cancer treatment skills and research through the Master in Molecular Oncology 2025-26 at @ceb_edu Nonstop progress! @idibaps @hospitalclinic
1
2
22